resveratrol has been researched along with Experimental Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, RA; Dumaguin, M; Gautam, SC; Janakiraman, N; Xu, YX | 1 |
1 other study(ies) available for resveratrol and Experimental Leukemia
| Article | Year |
|---|---|
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Purging; Bone Marrow Transplantation; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Graft Survival; HL-60 Cells; Humans; Leukemia, Experimental; Male; Mice; Mice, Inbred C3H; Resveratrol; Stilbenes; Tumor Cells, Cultured; U937 Cells; Whole-Body Irradiation | 2000 |